Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedUpgrade notice to v3.2.0 with a government-operating-status disclaimer; removal of v3.0.2 indicates the version update.SummaryDifference2%
- Check21 days agoChange DetectedThe page has updated the EMERALD trial entry with a new Phase 3 record dated 2025-09-15, replacing the previous 2024-10-30 version. Core trial details (design, endpoints, eligibility, arms) are retained but refreshed; minor wording and date formats updated. If no significant content changes beyond the update, note that this is an updated trial record rather than a new conceptual change.SummaryDifference3%
- Check36 days agoChange DetectedVersion bumped to v3.0.1 and a Back to Top link added. The previous version tag v3.0.0-post.1-g752effb-HEAD has been removed.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content.SummaryDifference0.0%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous locations and the introduction of Elacestrant, a new treatment for advanced breast cancer. Several previous locations and medications have been removed, indicating a shift in focus and content relevance.SummaryDifference16%
- Check57 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.